Login / Signup

Pharmacokinetics and Safety of Intravenous and Subcutaneous Auto-injector Single-dose Belimumab in Healthy Chinese Volunteers: A phase 1, Randomized, Open-label Study.

Xianmin MengQianqian WangShunquan WuDi PuAmber ZhangSun FangXuan ZhouHongzhou Lu
Published in: Rheumatology and therapy (2021)
NCT04136145.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • systemic lupus erythematosus
  • double blind
  • phase ii study
  • high dose
  • study protocol
  • placebo controlled
  • squamous cell carcinoma
  • low dose